Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schryber

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Oncology Nursing Forum|July 1, 1987
Autologous bone marrow transplantationS Schryber, C R Lacasse, M Barton-Burke
Cancer Research|September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapyJ P Eder, R C Bast, W P Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow supportA D Elias, L J Ayash, J P Eder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancerJ P Eder, K Antman, W Peters, et al.
Cancer Treatment Reports|February 1, 1987
High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experienceK Antman, J P Eder, A Elias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trialW P Peters, J P Eder, W D Henner, et al.
Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Oncology Nursing Forum|July 1, 1987
Autologous bone marrow transplantationS Schryber, C R Lacasse, M Barton-Burke
Cancer Research|September 1, 1986
Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapyJ P Eder, R C Bast, W P Peters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow supportA D Elias, L J Ayash, J P Eder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1986
High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancerJ P Eder, K Antman, W Peters, et al.
Cancer Treatment Reports|February 1, 1987
High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experienceK Antman, J P Eder, A Elias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trialW P Peters, J P Eder, W D Henner, et al.
Archives of Dermatology|June 1, 1988
Malignant melanoma. Treatment with high-dose combination alkylating agent chemotherapy and autologous bone marrow supportT C Shea, K H Antman, J P Eder, et al.
Pageof 1